📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. (2020)

First Author: O'Cathail SM

Attributed to: Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cancergen.2020.08.006

PubMed Identifier: 32871287

Publication URI: http://europepmc.org/abstract/MED/32871287

Type: Journal Article/Review

Volume: 248-249

Parent Publication: Cancer genetics